Skip to main content

Main menu

  • About
    • Leadership
    • Our Team
    • Vision, Mission and Values
    • Health and Economic Impact
    • Strategic Plan
    • News and Stories
    • Careers
  • Research
    • Research Focus
      • Brain Health
      • Cancer
      • Digital Health
      • Healthy Aging and Mobility
      • Heart Health
      • Immune System
      • Injury and Rehabilitation
      • Lung Health
      • Mental Health and Substance Use
      • Other Research Focus Areas
    • Research Centres and Programs
      • BC Centre on Substance Use
      • Centre for Aging SMART
      • Centre for Clinical Epidemiology and Evaluation
      • Centre for Lung Health
      • Dilawri Cardiovascular Institute
      • Djavad Mowafaghian Centre for Brain Health
      • International Collaboration On Repair Discoveries
      • M. H. Mohseni Institute of Urologic Sciences
      • Ovarian Cancer Research Centre
      • Community Research Program
      • Emergency Medicine Research Program
      • Hematology Research Program
      • Skin Research Program
    • Research Cores
      • Clinical Trials Platform
      • VCH-VCHRI AI Hub
      • Indigenous Health Research Unit
    • Researcher Directory
    • Events and Workshops
    • Participate in Research
  • Research Services
    • New to VCHRI
      • Working at VCHRI
      • Regulations and Training
      • Membership with VCHRI
    • Research Development
      • Internal Awards
      • Research Facilitation
      • Grant Management
      • Learning and Development
    • Clinical Trials Administration
      • Contract Facilitation
      • Operational Approval
      • Research Privacy
      • Clinical Trials Resources
    • Research Support
      • Communications and Media Relations
      • Financial Policies and Procedures
      • VCH-VCHRI AI Hub
    • Internal Awards
    • Clinical Research
    • Indigenous Research
  • Clinical Trials
    • Clinical Trials Platform
      • Phase 1 Clinical Trials Research Unit
      • Hematology Research Unit
      • Clinical Research Unit
    • Find a Study
    • Researcher Directory
  • Participate in Research
    • Reasons to Participate
    • Participant Stories
    • Find a Study
    • Recruitment Support

User menu

  • Log in

Breadcrumb

  1. Home
  2. Participate in Research
  3. Investigating the safety of an experimental drug in people with ALS
Research Study

First in Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of Intrathecally Administered ALN-SOD in Participants with Amyotrophic Lateral Sclerosis and SOD1 Mutations (GOALS Study - ALN-SOD for ALS)

Principal Investigator
Erik Pioro

Overview

Body Locations and Systems
Brain and Nerves
Amyotrophic Lateral Sclerosis
Immune System
Disorders and Conditions
Genetics
ClinicalTrials.gov#
NCT06351592
Status
Recruiting
Start/End Dates
Nov 1, 2026 May 31, 2029
Locations
Djavad Mowafaghian Centre for Brain Health
Vancouver General Hospital
Name/Title
Nimmy George, Research Coordinator
Phone
604-827-4573
Email Address
nimmy.george@vch.ca
Purpose of Study

The purpose of this Phase 1b/2 study is to evaluate an experimental drug, ALN-SOD, in a small group of participants for the first time. Phase I trials assess safety, determine appropriate dosage ranges and identify potential side effects. This study focuses on individuals with amyotrophic lateral sclerosis (ALS) who have a change in the SOD1 gene. The primary aim of the study is to see how safe and tolerable the study treatment (ALN-SOD) is in humans.

Eligible participants will be given doses of ALN-SOD or placebo into the fluid surrounding the spinal cord (intrathecal injection). The study doctor will do this by inserting a needle into the spine (spinal tap/lumbar puncture). During study visits, participants will also answer questions about their health and will undergo lumbar punctures. Participation may last up to four and a half years with up to 27 study visits, including some overnight stays for dosing.

Eligibility

Visit clinicaltrials.gov for more information.

Disclaimer

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.

Share

  • Facebook
  • Linkedin
  • Twitter
  • Instagram
  • Email

Get updates!

Join our newsletter mailing list to stay up to date on features and releases.

Subscribe

Quick Links

  • News and Stories
  • Careers
  • Events
  • Media Enquiries

Follow Us

  • LinkedIn
  • Instagram
  • Bluesky
  • YouTube

© 2026 VCHRI. All rights reserved.

  • Contact
  • Privacy Policy